Chinese Omicron-specific mRNA Covid-19 vaccine candidate to be trialed in UAE


The words "OMICRON SARS-COV-2" are seen reflected in a drop from a syringe needle in this illustration taken December 11, 2021. - Reuters

BEIJING, April 30 (Reuters): China's Suzhou Abogen Biosciences Co said its Covid-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

With Friday's announcement, Abogen joins Pfizer/BioNTech and Moderna in trialing candidates modified specifically against Omicron, a highly transmissible variant with increased resistance to antibodies elicited by existing shots.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Siblings killed in Tawau house fire
Japan PM Takaichi walks tightrope with Russia, China on Asia trip
Australia police charge Sydney man with terror offence
No 'big brother' in PN-BN talks, says Dr Sam
Three taken to hospital, 30 evacuated after Singapore kitchen fire at HDB flat
Five caught using smart devices to cheat in South Korea’s college entrance exam
Once unthinkable, Trump-Xi-Putin summit makes Russia and Beijing the biggest winners
‘Pyongyang growing uranium enrichment site’
Yogyakarta daycare principal jailed for child abuse
Lee hopes talks with North bring lasting peace

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read